|
[1]Edward LK.Autoimmune hepatitis[J].N Engl J Med, 2006, 354 (1) :54-66.
|
|
[2]Czaja AJ, Carpenter HA, Moore SB.HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients[J].Gut, 2007, 56 (10) :1471-1472.
|
|
[3]Seki T, Ota M, Furuta S, et al.HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients[J].Gastroenterology, 1992, 103 (3) :1041-1047.
|
|
[4]Pando M, Larriba J, Fernandez GC, et al.Pediatric and adult forms of type I autoimmune hepatitis in Argentina:evidence for differential genetic predisposition[J].Hepatology, 1999, 30 (6) :1374-1380.
|
|
[5]Czaja AJ, Donaldson PT.Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis[J].Immunol Rev, 2000, 174:250-259.
|
|
[6]Duarte-Rey C, Pardo AL, Rodriguez-Velosa Y, et al.HLA class II association with autoimmune hepatitis in Latin America:a meta-analysis[J].Autoimmun Rev, 2009, 8 (4) :325-331.
|
|
[7]Qiu DK, Ma X.Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients[J].J Gastroenterol Hepatol, 2003, 18 (1) :63-67.
|
|
[8]Czaja AJ, Carpenter HA.Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly[J].Hepatology, 2006, 43 (3) :532-538.
|
|
[9]Bittencourt PL, Goldberg AC, Cancado EL, et al.Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and[J].Am J Gastroenterol, 1999, 94 (7) :1906-1913.
|
|
[10]Djilali-Saiah I, Fakhfakh A, Louafi H, et al.HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis[J].J Hepatol, 2006, 45 (6) :844-850.
|
|
[11]Ben-Ari Z, Czaja AJ.Autoimmune hepatitis and its variant syndromes[J].Gut, 2001, 49 (4) :589-594.
|
|
[12]Suzuki Y, Ikeda K, Hirakawa M, et al.Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis[J].Dig Dis Sci, 2010, 55 (7) :2070-2076.
|
|
[13]Agarwal K, Czaja AJ, Jones DE, et al.Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis[J].Hepatology, 2000, 31 (1) :49-53.
|
|
[14]Umemura T, Ota M, Yoshizawa K, et al.Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese[J].Hepatol Res, 2008, 38 (7) :689-695.
|
|
[15]Hiraide A, Imazeki F, Yokosuka O, et al.Fas polymorphisms influence susceptibility to autoimmune hepatitis[J].Am J Gastroenterol, 2005, 100 (6) :1322-1329.
|
|
[16]Agarwal K, Czaja AJ, Donaldson PT.A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis[J].Tissue Antigens, 2007, 69 (3) :227-235.
|
|
[17]Fan L, Tu X, Zhu Y, et al.Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary J Clini Hepatol, June 2011, Vol.27, No.6cirrhosis in the Chinese[J].J Gastroenterol Hepatol, 2005, 20 (2) :249-255.
|
|
[18]Chen S, Zhao W, Tan W, et al.Association of TBX21 promoter polymorphisms with type 1 autoimmune hepatitis in Chinese[J].Hum Immuno, 2011, 72 (1) :69-73.
|
|
[19]Jiang W, Anderson MS, Bronson R, et al.Modifier loci condition autoimmunity provoked by Aire deficiency[J].J Exp Med, 2005, 202 (6) :805-815.
|
|
[20]Kerkar N, Choudhuri K, Ma Y, et al.Cytochrome P4502D6 (193-212) :a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease[J].J Immunol, 2003, 170 (3) :1481-1489.
|
|
[21]Berry PA, Smith-Laing G.Hepatitis A vaccine associated with autoimmune hepatitis[J].World J Gastroenterol, 2007, 13 (15) :2238-2239.
|
|
[22]Abraham C, Hart J, Locke SM, et al.A case of indometacin-induced acute hepatitis developing into chronic autoimmune hepatitis[J].Gastroenterology&Hepatology, 2008, 5 (3) :172-176.
|
|
[23]Leonid B, Elena R, Ignacio S, et al.Autoimmune hepatitis and hypergammaglobulinemic purpura associated with herbal medicine use[J].IMAJ, 2008, 10 (5) :390-391.
|
|
[24]Kerkar N, Choudhuri K, Ma Y, et al.Cytochrome P4502D6 (193-212) :a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease[J].J Immunol, 2003, 170 (3) :1481-1489.
|
|
[25]Vergani D, Mieli-Vergani G.The impact of autoimmunity on hepatocytes[J].Semin Liver Dis, 2007, 27 (2) :140-151.
|
|
[26]Holdener M, Hintermann E, Bayer M, et al.Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection[J].J Exp Med, 2008, 205 (6) :1409-1422.
|
|
[27]Bogdanos DP, Lenzi M, Okamoto M, et al.Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51[J].Int J Immunopathol Pharmacol, 2004, 17 (1) :83-92.
|
|
[28]Wies I, Brunner S, Henninger J.Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis[J].Lancet, 2000, 355 (9214) :1510-1515.
|
|
[29]Jiang H, Chess L.Regulation of immune responses by T cells[J].N Engl J Med, 2006, 354:1166-1176.
|
|
[30]Longhi MS, Hussain MJ, Mitry RR, et al.Functional study of CD4+CD25+regulatory T cells in health and autoimmune hepatitis[J].J Immunol, 2006, 176 (7) :4484-4491.
|
|
[31]胥萍, 李明, 吴敏娟, 等.自身免疫性肝病相关抗体与CD4+CD25+high调节性T细胞的临床意义探讨[J].中国现代药物应用, 2008, 2 (3) :1-3.
|
|
[32]Longhi MS, Ma Y, Mitry RR, et al.Effect of CD4+CD25+regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis[J].J Autoimmun, 2005, 25 (1) :63-71.
|
|
[33]Okumura A, Ishikawa T, Sato S, et al.Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4 (+) CD25 (+) T cells in patients with autoimmune hepatitis[J].Hepatol Res, 2008, 38 (9) :896-903.
|
|
[34]Longhi MS, Mitry RR.Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells[J].Hepatology, 2009, 50 (1) :130-142.
|
|
[35]Longhi MS, Ma Y.Impairment of CD4 (+) CD25 (+) regulatory T-cells in autoimmune liver disease[J].J Hepatol, 2004, 41 (1) :31-37.
|
|
[36]Yang XO, Pappu BP, Nurieva R, et al.T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma[J].Immunity, 2008, 28 (1) :29-39.
|
|
[37]Shahrara S, Huang Q, Mandelin AM, et al.Th117 cells in rheumatoid arthritis[J].Arthritis Res Ther, 2008, 10 (4) :R93.
|
|
[38]Kurasawa K, Hirose K, Sano H.Increased interleukin-17 production in patients with systemic sclerosis[J].Arthritis Rheum, 2000, 43 (11) :2455-2463.
|
|
[39]Nielsen OH, Kirman I, Rfidiger N, et al.Upregulation of interleukin-12 and-17 in active inflammatory bowel disease[J].Scand J Gastroenterol, 2003, 38 (2) :180-185.
|
|
[40]Lan RY, Salunga TL, Tsuneyama K, et al.Hepatic IL-17 responses in human and murine primary biliary cirrhosis[J].J Autoimmun, 2009, 32 (1) :43-51.
|
|
[41]Harada K, Shimoda S, Sato Y, et al.Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis[J].Clin Exp Immunol, 2009, 157 (2) :261-270.
|
|
[42]Yu H, Huang J, Liu Y, et al.IL-17 contributes to autoimmune hepatitis[J].J Huazhong Univ Sci Technolog Med Sci, 2010, 30 (4) :443-446.
|
|
[43]Oo, Hubscher SG, Adams DH.Autoimmune hepatitis:new paradigms in the pathogenesis, diagnosis, and management[J].Hepatol Int, 2010, 4 (2) :475-493.
|
|
[44]Nowak M, Stein-Streilein J.Invariant NKT cells and tolerance[J].Int Rev Immunol, 2007, 26 (1-2) :95-119.
|
|
[45]Takahashi H, Oikawa T, Amano K, et al.Intrahepatic NKT cell and soluble CD1d have a significant role in the immuno-pathogenesis of AIH but not PBC[J].Hepatology, 2006, 44 (Suppl 1) :227A-228A.
|
|
[46]Takeda K, Hayakawa Y, Van Kaer L, et al.Critical contribution of liver natural killer T cells to a murine model of hepatitis[J].Proc Natl Acad Sci U S A, 2000, 97 (10) :5498-5503.
|
|
[47]Chung H, Watanabe T, Kudo M, et al.Identification and characterization of IgG4-associated autoimmune hepatitis[J].Liver Int, 2010, 30 (2) :222-231.
|
|
[48]Lapierre P, Djilali-Saiah I, Vitozzi S, et al.A murine model of type 2 autoimmune hepatitis:xenoimmunization with human antigens[J].Hepatology, 2004, 39 (4) :1066-1074.
|
|
[49]Lapierre P, Beland K, Djilali-Saiah I, et al.Type 2 autoimmune hepatitis murine model:the influence of genetic background in disease development[J].J.Autoimmun, 2006, 26 (2) :82-89.
|
|
[50]Zierden M, Kuhnen E, Odenthal M, et al.Effects and regulation of autoreactive CD8+T cells in a transgenic mouse model of autoimmune hepatitis[J].Gastroenterology, 2010, 139 (3) :975-986.
|
DownLoad: